Literature DB >> 21221599

Uncontrolled home blood pressure in the morning is associated with nephropathy in Japanese type 2 diabetes.

Emi Ushigome1, Michiaki Fukui, Kazumi Sakabe, Muhei Tanaka, Shinobu Inada, Atsushi Omoto, Toru Tanaka, Wataru Fukuda, Haruhiko Atsuta, Masayoshi Ohnishi, Shin-Ichi Mogami, Yoshihiro Kitagawa, Yohei Oda, Masahiro Yamazaki, Goji Hasegawa, Naoto Nakamura.   

Abstract

The purposes of this study were to investigate the state of blood pressure control level and to investigate the relationship between blood pressure control level and nephropathy in Japanese type 2 diabetes. We measured clinic and home blood pressure in 923 type 2 diabetic patients. According to the criteria for hypertension in the Japanese Society of Hypertension Guidelines 2009, patients were classified into four groups by clinic systolic blood pressure (130 mmHg) and morning systolic blood pressure (125 mmHg), as follows: controlled hypertension (CH), white-coat hypertension (WCH), masked hypertension (MH), and sustained hypertension (SH). Of all patients, 13.9, 12.6, 13.3, and 60.2% were identified as having CH, WCH, MH, and SH, respectively. The average number of drugs prescribed was 1.8. We assessed the association between blood pressure control level and nephropathy in diabetic patients. The degree of urinary albumin excretion and the prevalence of nephropathy in diabetic patients were higher in MH and SH groups than those in the CH group. The majority of patients had poor blood pressure control, regardless of ongoing conventional antihypertensive therapy, and diabetic patients with MH and SH were associated with nephropathy. It is suggested that more aggressive antihypertensive treatment is recommended to prevent nephropathy in diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21221599     DOI: 10.1007/s00380-010-0107-z

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  29 in total

1.  Usefulness of home blood pressure measurement in the morning in patients with type 2 diabetes: long-term results of a prospective longitudinal study.

Authors:  Kyuzi Kamoi; Takako Ito; Masashi Miyakoshi; Shinichi Minagawa
Journal:  Clin Exp Hypertens       Date:  2010-05       Impact factor: 1.749

2.  Standards of medical care in diabetes--2007.

Authors: 
Journal:  Diabetes Care       Date:  2007-01       Impact factor: 19.112

3.  Validation of the Omron 705IT (HEM-759-E) oscillometric blood pressure monitoring device according to the British Hypertension Society protocol.

Authors:  Andrew Coleman; Paul Freeman; Stephen Steel; Andrew Shennan
Journal:  Blood Press Monit       Date:  2006-02       Impact factor: 1.444

4.  The bedtime administration of doxazosin controls morning hypertension and albuminuria in patients with type-2 diabetes: evaluation using home-based blood pressure measurements.

Authors:  Kyuzi Kamoi; Tomoo Ikarashi
Journal:  Clin Exp Hypertens       Date:  2005-05       Impact factor: 1.749

5.  Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study).

Authors:  R Sega; G Trocino; A Lanzarotti; S Carugo; G Cesana; R Schiavina; F Valagussa; M Bombelli; C Giannattasio; A Zanchetti; G Mancia
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

6.  Usefulness of home blood pressure measurement in the morning in type 2 diabetic patients.

Authors:  Kyuzi Kamoi; Masashi Miyakoshi; Satoshi Soda; Susumu Kaneko; Osamu Nakagawa
Journal:  Diabetes Care       Date:  2002-12       Impact factor: 19.112

7.  Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure.

Authors:  J E Liu; M J Roman; R Pini; J E Schwartz; T G Pickering; R B Devereux
Journal:  Ann Intern Med       Date:  1999-10-19       Impact factor: 25.391

8.  Long-term effects of telmisartan on blood pressure, the renin-angiotensin-aldosterone system, and lipids in hypertensive patients.

Authors:  Akiko Aoki; Tetsuya Ogawa; Hiroyuki Sumino; Hisao Kumakura; Yoshiaki Takayama; Shuichi Ichikawa; Kosaku Nitta
Journal:  Heart Vessels       Date:  2010-05-29       Impact factor: 2.037

9.  Prevalence of chronic kidney disease in the United States.

Authors:  Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey
Journal:  JAMA       Date:  2007-11-07       Impact factor: 56.272

10.  Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients.

Authors:  Guillaume Bobrie; Gilles Chatellier; Nathalie Genes; Pierre Clerson; Laurent Vaur; Bernard Vaisse; Joël Menard; Jean-Michel Mallion
Journal:  JAMA       Date:  2004-03-17       Impact factor: 56.272

View more
  9 in total

Review 1.  Clinical significance of home blood pressure and its possible practical application.

Authors:  Yutaka Imai
Journal:  Clin Exp Nephrol       Date:  2013-07-03       Impact factor: 2.801

2.  Out-of-Clinic Sympathetic Activity Is Increased in Patients With Masked Uncontrolled Hypertension.

Authors:  Mohammed Siddiqui; Eric K Judd; Byron C Jaeger; Hemal Bhatt; Tanja Dudenbostel; Bin Zhang; Lloyd J Edwards; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2019-01       Impact factor: 10.190

3.  Low dose of hydrochlorothiazide, in combination with angiotensin receptor blocker, reduces blood pressure effectively without adverse effect on glucose and lipid profiles.

Authors:  Wakaya Fujiwara; Hideo Izawa; Gen Ukai; Hiroatsu Yokoi; Daisuke Mukaide; Kohsuke Kinoshita; Shin-ichiro Morimoto; Junichi Ishii; Yukio Ozaki; Masanori Nomura
Journal:  Heart Vessels       Date:  2012-03-25       Impact factor: 2.037

4.  Diabetic nephropathy ameliorated in patients with normal home blood pressure compared to those with isolated high home systolic blood pressure: A 5-year prospective cohort study among patients with type 2 diabetes mellitus.

Authors:  Nobuko Kitagawa; Emi Ushigome; Noriyuki Kitagawa; Hidetaka Ushigome; Isao Yokota; Naoko Nakanishi; Masahide Hamaguchi; Mai Asano; Masahiro Yamazaki; Michiaki Fukui
Journal:  Diab Vasc Dis Res       Date:  2022 May-Jun       Impact factor: 3.541

5.  Impact of Isolated High Home Systolic Blood Pressure and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus: A 5-Year Prospective Cohort Study.

Authors:  Nobuko Kitagawa; Noriyuki Kitagawa; Emi Ushigome; Hidetaka Ushigome; Isao Yokota; Naoko Nakanishi; Masahide Hamaguchi; Mai Asano; Masahiro Yamazaki; Michiaki Fukui
Journal:  J Clin Med       Date:  2021-04-29       Impact factor: 4.241

6.  Beneficial effect of calcium channel blockers on home blood pressure variability in the morning in patients with type 2 diabetes.

Authors:  Emi Ushigome; Michiaki Fukui; Masahide Hamaguchi; Toru Tanaka; Haruhiko Atsuta; Masayoshi Ohnishi; Yohei Oda; Masahiro Yamazaki; Goji Hasegawa; Naoto Nakamura
Journal:  J Diabetes Investig       Date:  2013-03-04       Impact factor: 4.232

7.  Maximum morning home systolic blood pressure is an indicator of the development of diabetic nephropathy: The KAMOGAWA-HBP study.

Authors:  Takuro Okamura; Emi Ushigome; Nobuko Kitagawa; Chikako Oyabu; Toru Tanaka; Goji Hasegawa; Naoto Nakamura; Masayoshi Ohnishi; Sei Tsunoda; Hidetaka Ushigome; Isao Yokota; Masahide Hamaguchi; Mai Asano; Masahiro Yamazaki; Michiaki Fukui
Journal:  J Diabetes Investig       Date:  2019-05-07       Impact factor: 4.232

8.  Effects of dietary salt restriction on home blood pressure in diabetic patients with excessive salt intake: a pilot study.

Authors:  Emi Ushigome; Chikako Oyabu; Keiko Iwai; Nobuko Kitagawa; Aya Kitae; Tomonori Kimura; Isao Yokota; Hidetaka Ushigome; Masahide Hamaguchi; Mai Asano; Masahiro Yamazaki; Michiaki Fukui
Journal:  J Clin Biochem Nutr       Date:  2019-10-08       Impact factor: 3.114

9.  Threshold value of home pulse pressure predicting arterial stiffness in patients with type 2 diabetes: KAMOGAWA-HBP study.

Authors:  Noriyuki Kitagawa; Emi Ushigome; Shinobu Matsumoto; Chikako Oyabu; Hidetaka Ushigome; Isao Yokota; Mai Asano; Muhei Tanaka; Masahiro Yamazaki; Michiaki Fukui
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-15       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.